Skip header and navigation

1 records – page 1 of 1.

2001 serological survey in the Czech Republic--poliomyelitis.

https://arctichealth.org/en/permalink/ahliterature180596
Source
Cent Eur J Public Health. 2003 Dec;11 Suppl:S31-5
Publication Type
Article
Date
Dec-2003
Author
I. Matyásová
P. Rainetová
J. Cástková
Author Affiliation
Centre of Epidemiology and Microbiology, NRL for Enteroviruses, National Institute of Public Health, Prague, Czech Republic. matyasova@szu.cz
Source
Cent Eur J Public Health. 2003 Dec;11 Suppl:S31-5
Date
Dec-2003
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Antibodies, Viral - blood
Child
Child, Preschool
Czech Republic - epidemiology
Data Collection
Humans
Infant
Middle Aged
Poliomyelitis - blood - epidemiology - immunology - prevention & control
Poliovirus - immunology
Poliovirus Vaccine, Oral - administration & dosage
Serologic Tests
Abstract
Regular vaccination against poliomyelitis was started in 1960 with oral polio vaccine (OPV). Since 1992 a trivalent OPV has been administered in five doses within a nationwide vaccination campaign. The immunization coverage varies between 96.8% and 98.2% after 4 OPV doses, reaching 98.0% to 98.9% after the fifth dose. No case of indigenous poliomyelitis has been reported in the Czech Republic since the second half of 1960. In 2001, 3,230 sera were tested for the presence of antibodies against poliovirus of types 1, 2 and 3 using a virus neutralization microassay. The prevalence rates of antibodies vary between 96.0% and 100% for types 1 and 2 and between 95.1% and 100% for type 3, with the exception of the highest age group, in which the prevalence rates of antibodies against poliovirus of all three types are 92.2%.
PubMed ID
15080257 View in PubMed
Less detail